William Enright
2023
In 2023, William Enright earned a total compensation of $1.8M as Chief Executive Officer at Barinthus Biotherapeutics plc., a 13% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $307,989 |
|---|---|
| Option Awards | $842,168 |
| Salary | $610,000 |
| Other | $51,454 |
| Total | $1,811,611 |
Enright received $842.2K in option awards, accounting for 46% of the total pay in 2023.
Enright also received $308K in non-equity incentive plan, $610K in salary and $51.5K in other compensation.
Rankings
In 2023, William Enright's compensation ranked 607th out of 2,978 executives tracked by ExecPay. In other words, Enright earned more than 79.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 607 out of 2,978 | 80th |
Division Manufacturing | 342 out of 1,637 | 79th |
Major group Chemicals And Allied Products | 236 out of 906 | 74th |
Industry group Drugs | 232 out of 869 | 73rd |
Industry Pharmaceutical Preparations | 147 out of 627 | 77th |
Source: SEC filing on March 22, 2024.
Enright's colleagues
We found two more compensation records of executives who worked with William Enright at Barinthus Biotherapeutics plc. in 2023.